Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Operating Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹2,515 Cr₹190,193 Cr₹1,991 Cr₹165 Cr₹14,447 Cr

What is the latest Operating Profit of MANKIND PHARMA ?

The latest Operating Profit ratio of MANKIND PHARMA is ₹2,515 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹2,515 Cr
Mar2024₹190,193 Cr
Mar2023₹1,991 Cr
Mar2022₹165 Cr
Mar2021₹14,447 Cr

How is Operating Profit of MANKIND PHARMA Trending?

Years Operating Profit % Change
Mar2025 ₹2,515 Cr
-98.68
Mar2024 ₹190,193 Cr
9,454.83
Mar2023 ₹1,991 Cr
1,107.04
Mar2022 ₹165 Cr
-98.86
Mar2021 ₹14,447 Cr -

Compare Operating Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,845.3 Cr 0.6% 7.3% 10.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,704.0 Cr -0.5% 3.9% 12.1% Stock Analytics
DIVIS LABORATORIES ₹173,684.0 Cr -3.1% -0.1% 0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,093.0 Cr 3.1% 6.7% 45.5% Stock Analytics
CIPLA ₹117,699.0 Cr 1.4% 4.8% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹111,792.0 Cr 0.8% 3.9% 1.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.6%

7.3%

10.3%

SENSEX

1%

2.9%

-6.1%


You may also like the below Video Courses